Loading...

Tony Chou, MD

TitleAssociate Clinical Professor
InstitutionUniversity of California San Francisco
DepartmentMedicine
Address533 Parnassus Avenue
San Francisco CA 94117
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoClinical Fellowship School of Medicine - Internal Medicine
    University of California, San FranciscoResidency School of Medicine

    Collapse Overview 
    Collapse Overview
    Tony M. Chou is a general partner at the Vertical Group, a venture capital firm focused on the fields of medical technology and biotechnology.

    As an investor, Dr. Chou serves on the Board of Directors of several venture-backed companies.

    https://www.linkedin.com/in/tonychouverticalgroup

    Additional UCSF service includes participation as a member of the Masters of Translational Medicine Advisory Board. The MTM is a joint masters-level program which spans UCSF and UC Berkeley.


    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Pinter L, Ribo M, Loh C, Lane B, Roberts T, Chou TM, Kolvenbach RR. Safety and feasibility of a novel transcervical access neuroprotection system for carotid artery stenting in the PROOF Study. J Vasc Surg. 2011 Nov; 54(5):1317-23. PMID: 21658889.
      View in: PubMed
    2. McNulty E, Cohen J, Chou T, Shunk K. A "grapple hook" technique using a deflectable tip catheter to facilitate complex proximal circumflex interventions. Catheter Cardiovasc Interv. 2006 Jan; 67(1):46-8. PMID: 16331693.
      View in: PubMed
    3. Ruygrok PN, Ormiston JA, Stewart JT, Webster MW, El Jack S, Simpson-Plaumann S, Kay IP, Chou TM. Initial experience with a new femoral artery closure device following percutaneous coronary intervention with glycoprotein IIb/IIIa inhibition. Catheter Cardiovasc Interv. 2005 Oct; 66(2):185-91. PMID: 16152652.
      View in: PubMed
    4. Hermiller J, Simonton C, Hinohara T, Lee D, Cannon L, Mooney M, O'Shaughnessy C, Carlson H, Fortuna R, Yarbrough CA, Zapien M, Chou T. Clinical experience with a circumferential clip-based vascular closure device in diagnostic catheterization. J Invasive Cardiol. 2005 Oct; 17(10):504-10. PMID: 16204741.
      View in: PubMed
    5. Hutchison SJ, Browne AE, Ko E, Chou TM, Zellner C, Komesaroff PA, Chatterjee K, Sudhir K. Dehydroepiandrosterone sulfate induces acute vasodilation of porcine coronary arteries in vitro and in vivo. J Cardiovasc Pharmacol. 2005 Sep; 46(3):325-32. PMID: 16116338.
      View in: PubMed
    6. Chou TM. Vascular complications and arteriotomy closure devices during percutaneous coronary procedures. J Am Coll Cardiol. 2005 Jun 21; 45(12):2095-6; author reply 2096. PMID: 15963417.
      View in: PubMed
    7. Ruygrok PN, Chou TM. StarClose femoral arteriotomy closure device: an advance in arterial closure. Expert Rev Med Devices. 2005 May; 2(3):247-52. PMID: 16288587.
      View in: PubMed
    8. Nishino M, Youn HJ, Gheorghevici D, Zellner C, Chou TM, Sudhir K, Redberg RF. Effect of intracoronary estradiol on postischemic microvascular damage in a porcine model: a myocardial contrast echocardiographic study. Angiology. 2003 Nov-Dec; 54(6):701-9. PMID: 14666959.
      View in: PubMed
    9. Kereiakes DJ, Szyniszewski AM, Wahr D, Herrmann HC, Simon DI, Rogers C, Kramer P, Shear W, Yeung AC, Shunk KA, Chou TM, Popma J, Fitzgerald P, Carroll TE, Forer D, Adelman DC. Phase I drug and light dose-escalation trial of motexafin lutetium and far red light activation (phototherapy) in subjects with coronary artery disease undergoing percutaneous coronary intervention and stent deployment: procedural and long-term results. Circulation. 2003 Sep 16; 108(11):1310-5. PMID: 12939212.
      View in: PubMed
    10. Chou TM, Woodburn KW, Cheong WF, Lacy SA, Sudhir K, Adelman DC, Wahr D. Photodynamic therapy: applications in atherosclerotic vascular disease with motexafin lutetium. Catheter Cardiovasc Interv. 2002 Nov; 57(3):387-94. PMID: 12410519.
      View in: PubMed
    11. Michaels AD, Appleby M, Otten MH, Dauterman K, Ports TA, Chou TM, Gibson CM. Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial. J Invasive Cardiol. 2002 Jun; 14(6):299-302. PMID: 12042618.
      View in: PubMed
    12. Arora RR, Chou TM, Jain D, Fleishman B, Crawford L, McKiernan T, Nesto R, Ferrans CE, Keller S. Effects of enhanced external counterpulsation on Health-Related Quality of Life continue 12 months after treatment: a substudy of the Multicenter Study of Enhanced External Counterpulsation. J Investig Med. 2002 Jan; 50(1):25-32. PMID: 11813825.
      View in: PubMed
    13. Chou TM, Grossman W. The Role of Platelet-Targeted Strategies in Managing the Spectrum of Unstable Angina and Non-Q Wave Myocardial Infarction: Clinical Trials with Glycoprotein IIb/IIIa Inhibitors. J Invasive Cardiol. 1998 Dec; 10 Suppl D:8D-11D. PMID: 10762993.
      View in: PubMed
    14. Chou TM. Catheter-based intervention: pushing the envelope. J Am Coll Cardiol. 1998 Mar 01; 31(3):567-9. PMID: 9502636.
      View in: PubMed
    15. Hitchcock-DeGregori SE, Lewis SF, Chou TM. Tropomyosin lysine reactivities and relationship to coiled-coil structure. Biochemistry. 1985 Jun 18; 24(13):3305-14. PMID: 3927977.
      View in: PubMed
    Tony's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _